Workflow
Biocause Pharma(000627)
icon
Search documents
天茂集团(000627) - 2023 Q4 - 年度财报
2024-04-29 14:37
Liquidity and Financial Position - The company maintains a strong liquidity position, with liquidity coverage ratios meeting regulatory thresholds under both baseline and stress scenarios[2] - The company has not reported any significant liquidity risks or adverse events affecting its liquidity during the reporting period[2] - The total operating revenue for 2023 reached ¥49,698,873,747.47, showing a slight increase from ¥49,615,695,080.12 in 2022[26] - The operating revenue after deducting non-recurring income was ¥49,680,540,505.79 for 2023[26] - The net profit attributable to shareholders for 2023 was -¥651,758,543.03, a decrease of 337.82% from ¥274,051,117.04 in 2022[88] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥648,231,558.45, down 353.27% from ¥255,943,705.42 in 2022[88] - The net cash flow from operating activities was ¥9,534,242,316.33, an increase of 26.71% from ¥7,524,197,273.04 in 2022[88] - The total assets at the end of 2023 were ¥301,935,930,342.92, reflecting a growth of 4.62% from ¥288,598,690,187.29 at the end of 2022[88] - The net assets attributable to shareholders decreased by 3.84% to ¥20,590,055,885.37 from ¥21,411,955,513.57 in 2022[88] Governance and Compliance - The company has established a comprehensive governance structure, ensuring compliance with legal and regulatory requirements[6] - The board of directors has not raised any objections regarding company matters during the reporting period, indicating a unified governance approach[18] - The company’s board of directors has fulfilled its responsibilities effectively during the reporting period[30] - The company has established a comprehensive internal control system to ensure the normal operation of its business[61] - There were no significant defects or important defects identified in the internal control audit report, indicating effective internal controls[137] - The internal control audit report was disclosed on April 30, 2024, with a standard unqualified opinion[137] - The company has no recorded administrative penalties or violations during the reporting period[141] Employee and Training Development - The total pre-tax remuneration for the board members amounts to 462.06 million CNY, with the highest individual remuneration being 201.5 million CNY for the General Manager[16] - The training coverage rate for Guohua Life exceeded 90% in 2023, with various training programs implemented for different employee levels[22] - The company has established a three-tier training system to enhance operational efficiency and employee growth[22] - Guohua Life has upgraded its training programs to better meet new requirements, focusing on potential talent pools[22] - The company is committed to enhancing the quality of its operations through regular training for its board members and senior management[162] Business Strategy and Development - The company plans to enhance its fund sales business by leveraging its dual licenses in insurance and funds, aiming for a multi-layered financial service model[3] - The company has successfully integrated insurance and fund products to increase customer engagement and retention, targeting high-frequency interactions with clients[3] - The company aims to enhance its business model by integrating insurance with comprehensive financial services, focusing on innovative development models and expanding revenue sources[174] - The company has established a standardized product development process, adhering to the 2023 version of the product development management measures[164] - The company has diversified its revenue sources by integrating insurance and fund sales, becoming a leading national insurance intermediary[192] Community Engagement and Social Responsibility - The company conducted 22 public welfare projects in 2023, with total expenditures nearing CNY 1.25 million[142] - The company donated approximately CNY 180,000 worth of food to a nursing home in Sichuan Province, supporting rural revitalization efforts[142] - The company actively participated in disaster relief efforts, donating over 300 family disaster relief kits during the Hebei flood[151] Financial Performance of Subsidiaries - Huari Insurance achieved an insurance business revenue of CNY 40,377.95 million in 2023, a 6.76% increase from CNY 37,819.75 million in 2022[196] - The net profit for Huari Insurance in 2023 was CNY -1,155.21 million, representing a 338.60% decrease compared to CNY 484.16 million in 2022[196] - Total assets increased by 4.95% to CNY 295,177.77 million as of December 31, 2023, up from CNY 281,267.34 million in 2022[197] - Huari Insurance's investment income decreased by 17.96% to CNY 8,781.59 million in 2023, down from CNY 10,703.97 million in 2022[196] - Huari Insurance's return rate decreased to 8.44% in 2023 from 13.29% in 2022, indicating improved customer retention[196] Technology and Innovation - The company has developed proprietary technology platforms, including the Huari e-home App and various WeChat mini-programs, to improve customer service and operational management[193] - The company maintains a digital management capability, focusing on IT infrastructure, data governance, and risk prevention[155]
天茂集团:天茂集团关于举行2023年度业绩说明会并征集投资者问题的公告
2024-04-29 14:35
证券代码:000627 证券简称:天茂集团 公告编号:2024-024 天茂实业集团股份有限公司 关于召开 2023 年度业绩说明会并征集投资者问题的公告 天茂实业集团股份有限公司董事会 2024 年 4 月 29 日 天茂实业集团股份有限公司定于 2024 年 5 月 17 日(星期五)下午 15:00-17:00 在全景 网举办 2023 年度业绩说明会,本次年度业绩说明会将采用网络远程的方式举行,投资者可登 陆全景网"投资者关系互动平台"(https://ir.p5w.net)参与本次年度业绩说明会。 出席本次说明会的人员有:公司董事长刘益谦先生、总经理周文霞女士、公司财务总监陈 大力先生、公司独立董事姜海华先生、公司董事会秘书龙飞先生、国华人寿保险股份有限公司 副总经理、财务负责人冀爱萍女士。 为充分尊重投资者、提升交流的针对性,现就公司 2023 年度业绩说明会提前向投资者公 开征集问题,广泛听取投资者的意见和建议。投资者可于 2024 年 5 月 16 日(星期四)17:00 前访问 https://ir.p5w.net/zj/,或扫描下方二维码,进入问题征集专题页面,或将所关注 问题发送至公司投 ...
天茂集团(000627) - 2024 Q1 - 季度业绩预告
2024-04-15 10:04
Financial Performance Expectations - The company expects a net profit loss of between 80 million and 110 million yuan for Q1 2024, compared to a profit of 45.21 million yuan in the same period last year[2]. - The net profit after deducting non-recurring gains and losses is expected to be a loss of between 88 million and 118 million yuan, compared to a profit of 43.72 million yuan last year[2]. - The basic earnings per share are projected to be a loss of between 0.016 yuan and 0.022 yuan, compared to earnings of 0.01 yuan per share in the previous year[2]. Subsidiary Performance - The company’s subsidiary, Guohua Life, reported original insurance premium income of 15.206 billion yuan in Q1 2024, indicating a stable overall scale[5]. - Guohua Life aims to maintain a stable premium income while adjusting business pace and structure according to market conditions, focusing on long-term value and risk protection business development[4]. Factors Affecting Performance - The decline in performance is attributed to the downward trend in the 750-day moving average of the national bond yield curve, leading to increased reserve provisions by Guohua Life and reduced investment income[4]. Business Strategy and Outlook - The company plans to continue optimizing its business structure and asset allocation, enhancing operational capabilities through new technology applications and talent reserves[4]. - The financial department's preliminary calculations form the basis of this earnings forecast, with detailed disclosures to follow in the Q1 2024 report[6]. - The company emphasizes the importance of cautious decision-making for investors due to the preliminary nature of the earnings forecast[6]. Announcement Details - The announcement was made by the board of directors on April 15, 2024[7].
天茂集团(000627) - 2023 Q4 - 年度业绩
2024-04-15 10:04
Financial Performance - The total operating revenue for 2023 was RMB 4,972,582.34 million, a year-on-year increase of 0.22%[2] - The net profit attributable to shareholders was -RMB 65,178.48 million, a significant decline from RMB 27,405.11 million in the previous year[3] - The basic earnings per share for 2023 was -RMB 0.13, compared to RMB 0.06 in the previous year[3] - The weighted average return on net assets was -3.10%, a decrease of 4.35 percentage points from 1.25% in the previous year[3] Assets and Equity - The total assets at the end of 2023 were RMB 30,193,497.68 million, reflecting a growth of 4.62% compared to the previous year[2] - The equity attributable to shareholders decreased by 3.84% to RMB 2,059,002.96 million from RMB 2,141,195.55 million[2] Business Strategy - The original insurance premium income for 2023 was RMB 40.026 billion, maintaining stability compared to 2022[3] - The company plans to optimize its business structure and asset allocation while enhancing new technology applications and talent reserves[3] - The company aims to adjust its business pace and structure according to market conditions to promote long-term value and risk protection business development[3] Audit and Reporting - The financial data presented is preliminary and subject to audit, with potential discrepancies in the final annual report[7]
天茂集团:天茂实业集团股份有限公司关于国华人寿保险股份有限公司保费收入的自愿性信息披露公告
2024-04-12 12:13
证券代码:000627 证券简称:天茂集团 公告编号:2024-013 天茂实业集团股份有限公司 关于国华人寿保险股份有限公司保费收入的自愿性信息披露公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述 或重大遗漏。 天茂实业集团股份有限公司控股子公司国华人寿保险股份有限公司按照"坚定转型发展、 突出价值成长、全面提升能力、迈向成熟险企"的总体思路推进业务发展,深耕价值业务, 持续推动业务结构优化,2024 年 1 月 1 日至 2024 年 3 月 31 日期间累计原保险保费收入约为 人民币 1,520,579.50 万元。上述原保险保费收入数据未经审计,提请投资者注意。 特此公告。 天茂实业集团股份有限公司董事会 2024 年 4 月 12 日 1 ...
天茂集团:天茂实业集团股份有限公司关于国华人寿保险股份有限公司保费收入的自愿性信息披露公告
2024-03-14 10:38
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述 或重大遗漏。 2024 年 3 月 14 日 1 天茂实业集团股份有限公司控股子公司国华人寿保险股份有限公司按照"坚定转型发展、 突出价值成长、全面提升能力、迈向成熟险企"的总体思路推进业务发展,深耕价值业务, 持续推动业务结构优化,2024 年 1 月 1 日至 2024 年 2 月 29 日期间累计原保险保费收入约为 人民币 1,138,702.77 万元。上述原保险保费收入数据未经审计,提请投资者注意。 特此公告。 天茂实业集团股份有限公司董事会 证券代码:000627 证券简称:天茂集团 公告编号:2024-012 天茂实业集团股份有限公司 关于国华人寿保险股份有限公司保费收入的自愿性信息披露公告 ...
天茂集团:天茂实业集团股份有限公司关于国华人寿保险股份有限公司保费收入的自愿性信息披露公告
2024-02-07 10:38
证券代码:000627 证券简称:天茂集团 公告编号:2024-011 天茂实业集团股份有限公司 关于国华人寿保险股份有限公司保费收入的自愿性信息披露公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述 或重大遗漏。 1 天茂实业集团股份有限公司控股子公司国华人寿保险股份有限公司按照"坚定转型发展、 突出价值成长、全面提升能力、迈向成熟险企"的总体思路推进业务发展,深耕价值业务, 持续推动业务结构优化,2024 年 1 月 1 日至 2024 年 1 月 31 日期间累计原保险保费收入约为 人民币 718,919.65 万元。上述原保险保费收入数据未经审计,提请投资者注意。 特此公告。 天茂实业集团股份有限公司董事会 2024 年 2 月 7 日 ...
天茂集团:董事会公告
2024-01-29 11:44
证券代码:000627 证券简称:天茂集团 公告编号:2024-010 天茂实业集团股份有限公司 第九届董事会第十四次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 天茂实业集团股份有限公司(以下简称本公司)第九届董事会第十四次会议 通知于2024年1月18日分别以电子邮件方式送达全体董事、监事及全体高级管理 人员。会议于2024年1月29日在公司会议室以现场和通讯相结合的方式召开,会 议应到董事7人,实到董事7人。其中,以通讯表决方式出席会议的董事有刘益谦 先生、周文霞女士、姜海华先生。会议由副董事长周文霞女士主持,公司监事和 高级管理人员列席了会议。会议的召集、召开符合有关法律、行政法规、部门规 章和公司章程的规定。 二、董事会会议审议情况 审议通过了《关于调整董事会专门委员会成员的议案》 鉴于本公司在2024年1月29日召开的2024年第一次临时股东大会上,审议通 过了《关于独立董事辞职暨选举独立董事的议案》,选举胡兵先生为公司新任独 立董事,对公司第九届董事会专门委员会成员调整如下: 决策与咨询委员会成员:刘益谦先生 ...
天茂集团:2024年第一次临时股东大会决议公告
2024-01-29 11:44
证券代码:000627 证券简称:天茂集团 公告编号:2024-009 天茂实业集团股份有限公司 2024年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 特别提示: 本次股东大会未出现否决议案的情形,不涉及变更以往股东大会已通过的决议的情 形。 一、会议召开和出席情况 (一)会议召开情况 1、召开时间 现场会议时间:2024 年 1 月 29 日(星期一)下午 14:00 起。 网络投票时间:通过深圳证券交易所交易系统进行网络投票的时间为2024年1月 29日交易日上午9:15~9:25,9:30~11:30,下午13:00~15:00; 通过深圳证券交易所互联网投票系统投票的开始时间(2024年1月29日上午9:15) 至投票结束时间(2024年1月29日下午15:00)间的任意时间。 2、会议地点:天茂实业集团股份有限公司会议室(湖北省荆门市漳河新区天山路 1 号(国华汇金中心)1 幢 2 楼) 出席会议的股东及股东授权委托代表人数共 20 人,代表股份 2,889,575,895 股, 占公司有表决权股份总数的 58.486 ...
天茂集团:天茂集团2024年第一次临时股东大会法律意见书
2024-01-29 11:41
上海市锦天城(武汉)律师事务所 关于天茂实业集团股份有限公司 二○二四年第一次临时股东大会的 法律意见书 上海市锦天城(武汉)律师事务所(以下简称"本所")接受天茂实业集团 股份有限公司(以下简称"公司")委托,委派本律师出席公司二○二四年第一 次临时股东大会(以下简称"本次股东大会"),本律师根据《中华人民共和国公 司法》(以下简称《公司法》)《上市公司股东大会规则》等法律、法规、规章和 其他规范性文件以及《天茂实业集团股份有限公司章程》(以下简称《公司章程》) 的有关规定,出具本法律意见书。 为出具本法律意见书,本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则(试行)》等规定,严格履行 了法定职责,遵循了勤勉尽责和诚实信用原则,对本次股东大会所涉及的相关事 项进行了必要的核查和验证,核查了本所认为出具该法律意见书所需的相关文件、 资料,并参加了公司本次股东大会的全过程。本所保证本法律意见书所认定的事 实真实、准确、完整,所发表的结论性意见合法、准确,不存在虚假记载、误导 性陈述或者重大遗漏,并愿意承担相应法律责任。 本所同意将本法律意见书与本次股东大会的决议一并 ...